Hologic Diagenode — Epigenomics Solutions & Services

Hologic Diagenode is a leading global provider of complete solutions for epigenetics research, biological sample preparation, and biomarker discovery. Headquartered in Liège, Belgium, and operating globally, the company was acquired by Hologic, Inc. in 2021 and brings over 20 years of focused expertise in epigenomics.

Hologic Diagenode offers an integrated portfolio spanning instruments, reagent kits, validated antibodies, and end-to-end epigenomics profiling services — covering chromatin analysis (ChIP-seq, CUT&Tag, ATAC-seq), DNA methylation (WGBS, RRBS, MeDIP), RNA sequencing, and advanced bioinformatics powered by AI. Its proprietary Bioruptor® shearing system and IP-Star® automation platform are recognised as industry standards in chromatin sample preparation.

The company's epigenomics services support biomarker discovery and validation across oncology, liquid biopsy, and translational medicine — serving pharmaceutical companies, academic research centres, and clinical laboratories globally.

More information: diagenode.com